5/20/2022 4:09:02 AM
Menarini Group And Radius Health Announce Phase 3 EMERALD Study Meets End Points Of Progression-free Survival
10/18/2021 8:38:19 AM
Radius Health Announces Positive Topline Results From ATOM Study
1/5/2021 8:38:54 AM
Endo Ventures Enters Licensing Agreement For Paladin Labs To Commercialize Abaloparatide In Canada
1/5/2021 8:22:41 AM
Radius Health Enters Definitive Agreements With Endo Ventures For Abaloparatide
11/2/2017 9:31:33 PM
Jefferies Is Lowering Radius Health, Inc. (RDUS) FY19 Estimate To -4.03 From -2.94
11/2/2017 9:31:11 PM
Jefferies Is Lowering Radius Health, Inc. (RDUS) FY18 Estimate To -5.19 From -3.85
11/2/2017 9:30:53 PM
Jefferies Is Cutting Radius Health, Inc. (RDUS) FY17 Estimate To -5.72 From -5.19
7/24/2017 7:18:42 AM
Jefferies Is Lowering Radius Health, Inc. (RDUS) 2017 Rev. Estimate To 20.6 M From 155.6 M
7/24/2017 7:18:21 AM
Jefferies Is Lowering Radius Health, Inc. (RDUS) 2017 Estimate To -5.20 From -2.09
7/24/2017 7:18:01 AM
Jefferies Is Lowering Radius Health, Inc. (RDUS) Q4 17 Estimate To -1.20 From -0.17
7/24/2017 7:17:49 AM
Jefferies Is Cutting Radius Health, Inc. (RDUS) Q3 17 Estimate To -1.31 From 0.67
2/24/2017 12:55:28 PM
Canaccord Is Lowering Radius Health, Inc. (RDUS) 2017 Estimate To -2.60 From -0.67
2/24/2017 12:54:21 PM
Canaccord Is Cutting Radius Health, Inc. (RDUS) 2017 Rev. Estimate To 35 M From 107 M
11/3/2016 12:16:51 PM
Jefferies Is Lowering Radius Health, Inc. (RDUS) 2018 Estimate To -3.62 From -3.43